Document is current
Any future updates will be listed below
-
Authors
Fusco, Anna F. https://orcid.org/0000-0003-4245-8290
Rana, Sabhya https://orcid.org/0000-0002-1303-6614
Jorgensen, Marda
Bindi, Victoria E.
Sunshine, Michael D. https://orcid.org/0000-0002-7133-4185
Shaw, Gerry
Fuller, David D. https://orcid.org/0000-0001-5013-5972
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL139708-01A1)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL153140-01)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (5T32HD043730-19)
Dr. Frank M Davis MD Chairman Emeritus Grant
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1K99NS133388-01A1)
- License Information
-
More Information
Article History
Received: 30 July 2024
Revised: 3 December 2024
Accepted: 12 December 2024
First Online: 3 January 2025
Competing interests
: GS is the owner, founder, and CEO of EnCor Biotechnology Inc. which supplied certain commercial reagents used in this report. He may therefore benefit from sales or equity growth.
: All procedures described in this manuscript involving rats and tissue were approved by the University of Florida Institutional Animal Care and Use Committee and in strict accordance with the US National Institute of Health (NIH) Guide for the Care and Use of Laboratory Animals.
